Your browser doesn't support javascript.
loading
Modified HyperCVAD Versus Bortezomib-HyperCAD in Patients With Relapsed/Refractory Multiple Myeloma.
Saraceni, Megan M; Scott, Emma; Maziarz, Richard T; Siegel, Matthew B; Bassale, Solange; Jiing, Susie; Medvedova, Eva.
Afiliación
  • Saraceni MM; Department of Pharmacy Services, Oregon Health and Science University, Portland, OR. Electronic address: saraceni@ohsu.edu.
  • Scott E; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Siegel MB; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Bassale S; Biostatistics Shared Resource, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
  • Jiing S; Department of Pharmacy Services, Oregon Health and Science University, Portland, OR.
  • Medvedova E; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR.
Clin Lymphoma Myeloma Leuk ; 18(1): e77-e84, 2018 01.
Article en En | MEDLINE | ID: mdl-29169873

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante Autólogo / Trasplante de Células Madre / Bortezomib / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante Autólogo / Trasplante de Células Madre / Bortezomib / Mieloma Múltiple / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article